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Nick E. J. West, MA, MD
Cambridge, United KingdomA 50-year-old man presented with exertional
angina and a positive treadmill test. Coronary
angiography demonstrated a signiﬁcant lesion in
the mid-right coronary artery, and he proceeded
to percutaneous coronary intervention. Because
implantation of a bioresorbable vascular scaffold
(BVS) (Abbott Vascular, Santa Clara, California)
was considered, intracoronary imaging was per-
formed using both intravascular ultrasound (IVUS)Figure 1. Coregistered Coronary Angiography, IVUS, and OCT After B
Coronary angiography after bioresorbable vascular scaffold (BVS) implan
grey-scale intravascular ultrasound (GS-IVUS), virtual histology intravascu
at sites 1 (right upper panel; 1A to 1C, respectively) and 2 (right lowe
From the Department of Interventional Cardiology, Papworth
Hospital, Cambridge, United Kingdom. Dr. West is a consultant for
Abbott Vascular and St. Jude Medical. All other authors have reported(Eagle-Eye Platinum, Volcano Corporation, San
Diego, California) and optical coherence tomog-
raphy (OCT) (Dragonﬂy C7, St. Jude Medical, St.
Paul, Minnesota) to accurately assess the proximal
and distal reference diameter. The lesion was
adequately pre-dilated with a 3.0 15-mm Emerge
balloon (Boston Scientiﬁc, Natick, Massachusetts)
with subsequent implantation of a 3.0  18-mm
BVS at 16 atm (Fig. 1, left panel).VS Implantation
tation (left panel). Corresponding coregistered images from
lar ultrasound (VH-IVUS), and optical coherence tomography (OCT)
r panel; 2A to 2C, respectively) identiﬁed on angiographic image.
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e42To ensure adequate expansion and apposition within the
scaffolded segment, additional runs of both IVUS and OCT
were performed. Post-deployment imaging at 2 coregistered
points (site 1, right upper panel; site 2, right lower panel)
revealed that the strut architecture and apposition were
difﬁcult to visualize on both grey-scale (1A and 2A) and
virtual histology (VH) IVUS (1B and 2B). Furthermore, the
spectral analysis of the backscatter on VH-IVUS artifactually
portrayed the struts as dense calcium. By contrast, coregis-
tered OCT images (1C and 2C) clearly show a fully
expanded and apposed scaffold. This case conﬁrms previous
reports of IVUS imaging performing poorly in scaffolded
segments (1) and highlights that OCT should be the
imaging modality of choice during BVS implantation.Reprint requests and correspondence: Dr. Nick West, Depart-
ment of Interventional Cardiology, Papworth Hospital, Papworth
Everard, Cambridge CB23 3RE, United Kingdom. E-mail: nick.
west@papworth.nhs.uk.
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